WebDisclosure WebDisclosure
Basculer en Français
10965 Companies
240131 Keywords
168908 Articles
129230 Press releases
Headlines Articles Press releases Tobra Medical Remove
  1. Home
  2. Companies
  3. Tobra Medical
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/24/2024 at 19:05, 1 year 11 months ago

    Tobra Medical Unveils Advanced Tobra Bone Basket at 2024 NASS Meeting

    Medical Devices Spine Surgery Tobra Medical Autograft Collection NASS 2024
  • BRIEF

    published on 09/24/2024 at 19:05, 1 year 11 months ago

    Tobra Medical dévoile le panier osseux avancé Tobra lors de la réunion NASS 2024

    Dispositifs Médicaux Chirurgie De La Colonne Vertébrale Tobra Medical NASS 2024 Prélèvement D'autogreffe
  • PRESS RELEASE

    published on 09/24/2024 at 19:00, 1 year 11 months ago

    Tobra Medical Presenting Next Generation Tobra Bone Basket Autograft Collection System at 2024 North American Spine Conference (NASS)

    Tobra Medical introduces the next generation Tobra Bone Basket at the 2024 NASS meeting, featuring a solid-state graft compressor and Sure Flow technology for optimal performance in autograft collection
    Medical Device Tobra Medical Autograft Collection Tobra Bone Basket NASS Meeting
    Logo of Tobra Medical
Accesswire
  • Published on 09/12/2026 at 02:35, 1 hour 13 minutes ago

    Gamma Resources Announces Extension of Private Placement Closing Date

  • Published on 09/11/2026 at 23:00, 4 hours 48 minutes ago

    Rio Grande Resources Engages Machai Capital for Investor Outreach

  • Published on 09/11/2026 at 22:05, 5 hours 43 minutes ago

    Usha Resources Announces Leadership Transition

  • Published on 09/11/2026 at 21:25, 6 hours 23 minutes ago

    Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects

  • Published on 09/11/2026 at 17:00, 10 hours 48 minutes ago

    Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE
EQS Group
  • Published on 09/11/2026 at 22:15, 5 hours 33 minutes ago

    Amrize Appoints Mario Gross as President of Building Envelope

  • Published on 09/11/2026 at 22:10, 5 hours 38 minutes ago

    Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference

  • Published on 09/11/2026 at 19:44, 8 hours 4 minutes ago

    DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031

  • Published on 09/11/2026 at 18:15, 9 hours 33 minutes ago

    CGTN: How BRICS creates new opportunities for Global South development

  • Published on 09/11/2026 at 18:07, 9 hours 41 minutes ago

    Holding(s) in Company

View all EQS
Les Echos
  • Published on 09/11/2026 at 07:00, 20 hours 48 minutes ago

    Transparantiekennisgeving van Baltisse Groep

  • Published on 09/11/2026 at 07:00, 20 hours 48 minutes ago

    Transparency notification by Baltisse Group

  • Published on 09/11/2026 at 07:00, 20 hours 48 minutes ago

    BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY

  • Published on 09/11/2026 at 07:00, 20 hours 48 minutes ago

    BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ

  • Published on 09/10/2026 at 19:30, 1 day 8 hours ago

    Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy